Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline

Details for Australian Patent Application No. 2002341260 (hide)

Owner PFIZER LIMITED

Inventors Smith, Janet Sarah; Macrae, Ross James; Humphrey, Michael John; Davis, John Douglas

Agent Shelston IP

Pub. Number AU-A-2002341260

PCT Number PCT/IB02/04040

PCT Pub. Number WO2003/032956

Priority 0124455.7 11.10.01 GB

Filing date 30 September 2002

Wipo publication date 28 April 2003

International Classifications

A61K 009/22 Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 009/52 Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 013/08 Drugs for disorders of the urinary system

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 0124455.7 11.10.01 GB

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002341260

6 April 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002341261-N-ALKYL-ADAMANTYL DERIVATIVES AS P2X7-RECEPTOR ANTAGONISTS

2002341259-USE AND EVALUATION OF A (2+2) PHOTOADDITION IN IMMOBILIZATION OF OLIGONUCLEOTIDES ON A THREE-DIMENSIONAL HYDROGEL MATRIX